These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32122925)

  • 61. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis.
    Lin P; He RQ; Huang ZG; Zhang R; Wu HY; Shi L; Li XJ; Li Q; Chen G; Yang H; He Y
    Aging (Albany NY); 2019 Apr; 11(7):2082-2097. PubMed ID: 30986203
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
    Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
    Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Genetic abnormalities in AML].
    Nakajima H
    Rinsho Ketsueki; 2019; 60(6):584-593. PubMed ID: 31281149
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
    Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
    Metzeler KH; Herold T; Rothenberg-Thurley M; Amler S; Sauerland MC; Görlich D; Schneider S; Konstandin NP; Dufour A; Bräundl K; Ksienzyk B; Zellmeier E; Hartmann L; Greif PA; Fiegl M; Subklewe M; Bohlander SK; Krug U; Faldum A; Berdel WE; Wörmann B; Büchner T; Hiddemann W; Braess J; Spiekermann K;
    Blood; 2016 Aug; 128(5):686-98. PubMed ID: 27288520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
    Dvinge H; Guenthoer J; Porter PL; Bradley RK
    Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
    Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia.
    Boda AR; Liu AJ; Castro-Pando S; Whitfield BT; Molldrem JJ; Al-Atrash G; Di Francesco ME; Jones P; Ager CR; Curran MA
    Cancer Res Commun; 2024 Mar; 4(3):911-918. PubMed ID: 38477596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
    Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
    Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.
    De Clara E; Gourvest M; Ma H; Vergez F; Tosolini M; Dejean S; Demur C; Delabesse E; Recher C; Touriol C; Martelli MP; Falini B; Brousset P; Bousquet M
    Haematologica; 2017 Oct; 102(10):1718-1726. PubMed ID: 28679652
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genome-wide identification of aberrant alternative splicing and RNA-binding protein regulators in acute myeloid leukaemia which may contribute to immune microenvironment remodelling.
    Yang Y; Zhang YM; Wang Y; Liu K; Cui SY; Luo YQ; Zheng W; Xu J; Duan W; Wang JY
    Carcinogenesis; 2023 Aug; 44(5):418-425. PubMed ID: 37209099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
    BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clusterization in acute myeloid leukemia based on prognostic alternative splicing signature to reveal the clinical characteristics in the bone marrow microenvironment.
    Zhang N; Zhang P; Chen Y; Lou S; Zeng H; Deng J
    Cell Biosci; 2020; 10():118. PubMed ID: 33062256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Splicing factor DHX15 affects tp53 and mdm2 expression via alternate splicing and promoter usage.
    McElderry J; Carrington B; Bishop K; Kim E; Pei W; Chen Z; Ramanagoudr-Bhojappa R; Prakash A; Burgess SM; Liu PP; Sood R
    Hum Mol Genet; 2019 Dec; 28(24):4173-4185. PubMed ID: 31691804
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
    Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
    BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Advances of study on prognostic factors of molecular biology in acute myeloid leukemia with normal cytogenetics].
    Han TJ; Xu XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1063-8. PubMed ID: 20723330
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients.
    Shivarov V; Gueorguieva R; Stoimenov A; Tiu R
    Leuk Res; 2013 Nov; 37(11):1445-50. PubMed ID: 23962568
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Splicing factor mutations and cancer.
    Yoshida K; Ogawa S
    Wiley Interdiscip Rev RNA; 2014; 5(4):445-59. PubMed ID: 24523246
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes.
    Madan V; Li J; Zhou S; Teoh WW; Han L; Meggendorfer M; Malcovati L; Cazzola M; Ogawa S; Haferlach T; Yang H; Koeffler HP
    Am J Hematol; 2020 Feb; 95(2):133-143. PubMed ID: 31680297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.